Sproutly Canada Inc. (SPR:CSE; SRUTF:OTCQB) achieved a key milestone in Q2/19, making its first commercial sale of cannabis flower, it announced in a news release.
Other highlights from the quarter ending Aug. 31, 2019 include Sproutly's cannabis producer Toronto Herbal Remedies (THR) submitting an amendment to Health Canada for a license to sell cannabis flower.
THR also successfully carried out an initial run employing the licensed proprietary aqueous phytorecovery process (APP) extraction technology. During early Q3/19, analytical methods were created and verified using the APP technology to detect, identify and measure cannabinoid levels in water-soluble and oil preparations developed from cannabis and hemp.
Further, Sproutly entered into a voluntary debt for shares settlement agreement with an arm's length creditor. Doing so settled an outstanding debt of $3,537,455 by issuing 4,716,606 common shares at a price of $0.75 per share and improved the cannabis firm's working capital position.
Subsequent to Q2/19, Sproutly hit another milestone, receipt of its flower sales license from Health Canada. With the license, effective Oct. 16, 2019, the company now can sell its dried flower and oil products to the Canadian market via authorized distributors and retailers. As well, Sproutly now can commercialize CALIBER, its line of premium cannabis products.
Finally, the company opened a new manufacturing plant near its THR production facility in Scarborough, Ontario.
"We anticipate more growth as we begin to generate revenue from the sales of our flower as we move into Q3/19," CEO Keith Dolo said in the release.
Read what other experts are saying about:
Disclosure:
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: Sproutly Canada. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this interview, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Sproutly Canada, a company mentioned in this article.
